New advice on AstraZeneca COVID-19 vaccine issued following rare blood clot link

blood clot

New advice has been issued by the MRHA and JCVI on the link between the COVID-19 AstraZeneca vaccine and thrombosis and thrombocytopenia

Please register to continue reading this content

Register for free

Guidelines is completely free for all UK-based healthcare professionals